Streetbeat News

Equity Actions

ATRA

Atara Biotherapeutics has entered into a definitive agreement for a registered direct offering, issuing pre-funded warrants to purchase over 27 million shares at $0.55 each, raising $15 million.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 8:26 pm

BXP

CCI

VNQ

VNQI

U.S. office space vacancies have reached their highest levels since 1979, with nearly 20% unleased in major cities by Q4 2023. The rise is attributed to overbuilding in the past and the shift to home and hybrid work models post-COVID-19. Texas cities like Houston, Dallas, and Austin face the highest vacancy rates, impacting local REITs such as Crown Castle Inc (CCI), which saw a 15.5% decline in 2023. Conversely, Boston Properties, Inc (BXP) in areas with lower vacancies saw a 5.3% increase. The article also compares U.S.-based REITs, like those in the Vanguard Real Estate Index Fund ETF (VNQ), which rose 6.2%, to the Vanguard Global ex-U.S. Real Estate Index Fund ETF (VNQI), with a smaller gain of 1.2%, reflecting challenges in the global market, particularly in China.

Portfolio Pulse from Neil Dennis

January 08, 2024 | 8:09 pm

BEN

Franklin Resources (NYSE:BEN) received mixed analyst ratings in the latest quarter, with 3 indifferent and 1 somewhat bearish. The average 12-month price target is now $27.0, up from $24.33. Analysts from Wells Fargo, TD Cowen, Morgan Stanley, and Deutsche Bank have adjusted their price targets and ratings. Franklin had $1.335 trillion in managed assets as of October 2023. The company's financial performance shows below industry average market capitalization, revenue growth, net margin, ROE, and ROA, but a conservative debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 8:00 pm

KMB

Kimberly-Clark Inc. (NYSE:KMB) shares increased by 0.54% to $122.91, with a 0.94% rise over the past month but a 9.53% fall over the past year. The stock's P/E ratio of 23.51 is lower than the Household Products industry average of 46.16, suggesting it might be undervalued or expected to perform worse than its peers. Investors are advised to consider the P/E ratio alongside other financial metrics and qualitative analysis for a comprehensive investment decision.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 8:00 pm

BRK.B

Charlie Munger, who passed away in November at 99, left behind valuable life lessons he shared with his children. Munger, known for his role at Berkshire Hathaway Inc (BRK), taught the importance of working with various clients to succeed, returning borrowed items in better condition, and the value of honesty in business. His children, Charles and Wendy, recounted specific instances where these lessons impacted their lives.

Portfolio Pulse from Adam Eckert

January 08, 2024 | 7:24 pm

ABSI

Absci (NASDAQ:ABSI) has received mixed analyst ratings over the past three months, with 4 analysts offering diverse views ranging from bullish to bearish. The average 12-month price target is $4.75, up from the previous $3.50, with a high estimate of $7.00 and a low of $3.00. Analysts from HC Wainwright & Co. and Keybanc have raised their price targets, reflecting a positive outlook on the company's performance. Despite a significant market capitalization, Absci faces revenue challenges with a -68.59% decline over 3 months. However, the company has a high net margin of -2956.18%, an ROE of -10.68%, and an ROA of -8.97%, with a low debt-to-equity ratio of 0.09.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 7:01 pm

IRTC

iRhythm Technologies (NASDAQ:IRTC) has been analyzed by 6 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $122.83, with a high of $136.00 and a low of $108.00, indicating a slight increase from the previous average of $122.40. Analysts from firms including Needham, Truist Securities, Citigroup, and Morgan Stanley have updated their ratings and price targets, reflecting their views on the company's performance and market conditions. iRhythm Technologies, a digital healthcare company, has seen a revenue growth of 19.96% as of September 30, 2023, but faces challenges with below-average net margin, ROE, and ROA, despite a conservative debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 7:01 pm

VTLE

Analysts have mixed views on Vital Energy (NYSE:VTLE), with recent ratings ranging from bullish to bearish. Over the last quarter, the total ratings included 4 bullish, 2 somewhat bullish, 1 indifferent, and 1 somewhat bearish. The average 12-month price target is now $62.75, down from $76.75, indicating an 18.24% decrease. Analysts from firms like Raymond James, Truist Securities, and others have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. Vital Energy, an independent energy company operating in the Permian Basin, has seen a -6.16% decline in revenue growth and has financial metrics below industry averages, including a net margin of 1.12% and an ROE of 0.29%.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 7:00 pm

VMC

Five analysts have recently updated their ratings on Vulcan Materials (NYSE:VMC), with an average 12-month price target of $242.4, down 2.13% from the previous average. Actions include ratings from 'Equal-Weight' to 'Buy' and price target changes. Vulcan Materials, a major producer of construction aggregates, showed a revenue growth of 4.67% but has a lower net margin and ROE compared to industry standards, and a high debt-to-equity ratio. Analysts' ratings are based on financial forecasts and company performance.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 6:01 pm

MLM

Analysts have provided mixed evaluations of Martin Marietta Materials (NYSE:MLM) with 6 ratings over the past three months. The average 12-month price target is $541.33, a 7.78% increase from the previous target. Analysts from firms like Morgan Stanley and Stifel have raised their price targets, reflecting a positive outlook. Martin Marietta, a major producer of construction aggregates, has shown strong financial health with a high market cap, positive revenue trend, and net margin, but has lower ROE and ROA compared to industry averages, and a higher debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 6:00 pm